Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
A 33-year-old woman with T(4c)N(3) breast cancer with metastases in the skeleton (M(1)) received five cycles of 5-fluorouracil, epirubicin, and cyclophosphamide (FEC regimen) before conception and during the first trimester. Salvage radiotherapy (28 Gy) was delivered during the 17th week. Tamoxifen and zolendronic acid were also administered throughout the second and third trimesters. The patient was not aware of her pregnancy until the 28th week. A female phenotypically normal infant was delivered in the 35th week of gestation by cesarean section. The child is functioning normally 12 months after delivery. The literature of anthracycline treatment during conception and the first trimester is reviewed. The effects of tamoxifen and biphosphonate therapy on the fetus during pregnancy are also discussed.
Andreadis
Charalampos
C
3rd Department of Clinical Oncology, Theagenion Cancer Hospital of Thessaloniki, 540 07 Thessaloniki, Greece. elkageba@otenet.gr
Charalampidou
Martha
M
Diamantopoulos
Nikolaos
N
Chouchos
Nikolaos
N
Mouratidou
Despina
D
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004164:Diphosphonates / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D011256:Pregnancy Outcome; D016879:Salvage Therapy; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects; D000077211:Zoledronic Acid
D004164:Diphosphonates; D007093:Imidazoles; D013629:Tamoxifen; D015251:Epirubicin; D000077211:Zoledronic Acid; D003520:Cyclophosphamide; D005472:Fluorouracil